| Source: CGL-Driver Genes |
| Type: Oncogene |
| DNA (cytosine-5-)-methyltransferase 3 alpha, commonly referred to as DNMT3A, is an enzyme that plays a crucial role in the process of DNA methylation, which is an important mechanism for regulating gene expression and maintaining genomic stability. The expression levels of DNMT3A and the presence of mutations can serve as prognostic markers in certain cancers. In some cancers, DNMT3A is overexpressed, leading to increased DNA methylation of tumor suppressor genes. Biological Consequences of DNMT3A Loss -Epigenetic drift rather than uniform hypomethylation -Persistence of stem-like transcriptional programs -Increased self-renewal of hematopoietic stem cells -Impaired differentiation with preserved viability Importantly, DNMT3A loss does not strongly increase proliferation on its own—it increases clonal persistence and evolutionary potential. |
| Normal Healthy |
| 1561- | Api, | Apigenin Reactivates Nrf2 Anti-oxidative Stress Signaling in Mouse Skin Epidermal JB6 P + Cells Through Epigenetics Modifications |
| - | in-vivo, | Nor, | JB6 |
| 2915- | LT, | Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | SNU-407 | - | in-vitro, | Nor, | FHC |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:86 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid